Mar 23, 2019
This year is METAvivor's 10th year anniversary and the organization's goal is to exceed $10 million for metastatic breast cancer research funding in 2019.
Jan 01, 2019
METAvivor Research and Support is proud to announce six additional metastatic breast cancer research awards totaling $1,050,000. The additional grant awards are a direct result of donor led fundraising.
Nov 06, 2018
METAvivor Research and Support announces 17 new grant awards for metastatic breast cancer research totaling $2,350,000. This banner year for grant awards is a result of METAvivor exceeding their Cancer Moon Shot goal of $2 million in research funding.
Oct 08, 2018
Patients will join with METAvivor to launch an ambitious advocacy agenda to help increase funding for research and to advocate for access to care for people with Stage IV, metastatic cancer
Apr 01, 2017
METAvivor will train stage IV metastatic breast cancer patients and their supporters from across the US on advocacy issues affecting this community.
Mar 01, 2017
METAvivor Research and Support, Inc. is requesting proposals for metastatic breast cancer research and has increased grant awards to $200,000 for this grant cycle.
Jan 31, 2017
METAvivor Research and Support announces that Patrick Quinn and Pamela King have joined our Board of Directors, and the organization has a new slate of officers.
Oct 31, 2016
METAvivor Research and Support announces seven new grant awards for metastatic breast cancer research. The 2016 grant awards hold promise for clinical trials that may have a significant and positive impact for metastatic cancer.
Oct 17, 2016
Inspired by the Cancer Moonshot and in collaboration with the Metastasis Research Society, METAvivor commits to funding $1 million in metastasis research grants in 2017, and doubling that amount in 2018.
Sep 27, 2016
METAvivor will partner with breast cancer organizations to launch an ambitious advocacy agenda to help increase funding for research and to improve access to social services for people with Stage IV, metastatic cancer.